Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial - Carr, R; Brocklehurst, P; Dore, C J (Lancet, 2009)
et al.